Literature DB >> 30026529

Anticancer therapy: Metabolic synthetic lethality.

M Teresa Villanueva.   

Abstract

Year:  2018        PMID： 30026529     DOI： 10.1038/nrd.2018.123

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  An inhibitor of oxidative phosphorylation exploits cancer vulnerability.

Authors:  Jennifer R Molina; Yuting Sun; Marina Protopopova; Sonal Gera; Madhavi Bandi; Christopher Bristow; Timothy McAfoos; Pietro Morlacchi; Jeffrey Ackroyd; Ahmed-Noor A Agip; Gheath Al-Atrash; John Asara; Jennifer Bardenhagen; Caroline C Carrillo; Christopher Carroll; Edward Chang; Stefan Ciurea; Jason B Cross; Barbara Czako; Angela Deem; Naval Daver; John Frederick de Groot; Jian-Wen Dong; Ningping Feng; Guang Gao; Jason Gay; Mary Geck Do; Jennifer Greer; Virginia Giuliani; Jing Han; Lina Han; Verlene K Henry; Judy Hirst; Sha Huang; Yongying Jiang; Zhijun Kang; Tin Khor; Sergej Konoplev; Yu-Hsi Lin; Gang Liu; Alessia Lodi; Timothy Lofton; Helen Ma; Mikhila Mahendra; Polina Matre; Robert Mullinax; Michael Peoples; Alessia Petrocchi; Jaime Rodriguez-Canale; Riccardo Serreli; Thomas Shi; Melinda Smith; Yoko Tabe; Jay Theroff; Stefano Tiziani; Quanyun Xu; Qi Zhang; Florian Muller; Ronald A DePinho; Carlo Toniatti; Giulio F Draetta; Timothy P Heffernan; Marina Konopleva; Philip Jones; M Emilia Di Francesco; Joseph R Marszalek
Journal:  Nat Med       Date:  2018-06-11       Impact factor: 53.440
  1 in total
  4 in total

Review 1.  Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets.

Authors:  Henriette Berg Andersen; Renata Ialchina; Stine Falsig Pedersen; Dominika Czaplinska
Journal:  Cancer Metastasis Rev       Date:  2021-12-02       Impact factor: 9.264

2.  Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin.

Authors:  Xiao-Ming Huang; Jia-Jun Huang; Jing-Jing Du; Na Zhang; Ze Long; You Yang; Fang-Fang Zhong; Bo-Wen Zheng; Yun-Fu Shen; Zhe Huang; Xiang Qin; Jun-He Chen; Qian-Yu Lin; Wan-Jun Lin; Wen-Zhe Ma
Journal:  Acta Pharmacol Sin       Date:  2021-02-19       Impact factor: 6.150

Review 3.  Development of synthetic lethality in cancer: molecular and cellular classification.

Authors:  Shijie Li; Win Topatana; Sarun Juengpanich; Jiasheng Cao; Jiahao Hu; Bin Zhang; Diana Ma; Xiujun Cai; Mingyu Chen
Journal:  Signal Transduct Target Ther       Date:  2020-10-19

4.  Development of Metabolic Synthetic Lethality and Its Implications for Thyroid Cancer.

Authors:  Sang-Hyeon Ju; Seong Eun Lee; Yea Eun Kang; Minho Shong
Journal:  Endocrinol Metab (Seoul)       Date:  2022-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.